118 related articles for article (PubMed ID: 18098001)
1. Methamphetamine users entering treatment: characteristics of the methamphetamine treatment project sample.
Christian DR; Huber A; Brecht ML; McCann MJ; Marinelli-Casey P; Lord RH; Reiber C; Lu TH; ; Galloway GP
Subst Use Misuse; 2007; 42(14):2207-22. PubMed ID: 18098001
[TBL] [Abstract][Full Text] [Related]
2. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
[TBL] [Abstract][Full Text] [Related]
4. Treatment response by primary drug of abuse: does methamphetamine make a difference?
Luchansky B; Krupski A; Stark K
J Subst Abuse Treat; 2007 Jan; 32(1):89-96. PubMed ID: 17175402
[TBL] [Abstract][Full Text] [Related]
5. Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia.
Wallace C; Galloway T; McKetin R; Kelly E; Leary J
Drug Alcohol Rev; 2009 Nov; 28(6):592-9. PubMed ID: 19930011
[TBL] [Abstract][Full Text] [Related]
6. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
McKetin R; Kelly E
Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
[TBL] [Abstract][Full Text] [Related]
7. A comparison of adolescent methamphetamine and other substance users in Hawai'i.
Kim RJ; Jackson DS
Hawaii Med J; 2008 Nov; 67(11):294-300, 302. PubMed ID: 19226910
[TBL] [Abstract][Full Text] [Related]
8. A descriptive analysis of participant characteristics and patterns of substance use in the CSAT methamphetamine treatment project: the first six months.
Reiber C; Galloway G; Cohen J; Hsu JC; Lord RH
J Psychoactive Drugs; 2000; 32(2):183-91. PubMed ID: 10908006
[TBL] [Abstract][Full Text] [Related]
9. The relationship between crystalline methamphetamine use and methamphetamine dependence.
McKetin R; Kelly E; McLaren J
Drug Alcohol Depend; 2006 Dec; 85(3):198-204. PubMed ID: 16723192
[TBL] [Abstract][Full Text] [Related]
10. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
Kinner SA; Degenhardt L
Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
[TBL] [Abstract][Full Text] [Related]
11. The clinical characteristics of adolescents reporting methamphetamine as their primary drug of choice: an examination of youth admitted to inpatient substance-abuse treatment in northern British Columbia, Canada, 2001-2005.
Callaghan RC; Brands B; Taylor L; Lentz T
J Adolesc Health; 2007 Mar; 40(3):286-9. PubMed ID: 17321434
[TBL] [Abstract][Full Text] [Related]
12. When treatment meets research: clinical perspectives from the CSAT Methamphetamine Treatment Project.
Obert JL; Brown AH; Zweben J; Christian D; Delmhorst J; Minsky S; Morrisey P; Vandersloot D; Weiner A
J Subst Abuse Treat; 2005 Apr; 28(3):231-7. PubMed ID: 15857723
[TBL] [Abstract][Full Text] [Related]
13. The CSAT methamphetamine treatment program: research design accommodations for "real world" application.
Huber A; Lord RH; Gulati V; Marinelli-Casey P; Rawson R; Ling W
J Psychoactive Drugs; 2000; 32(2):149-56. PubMed ID: 10908002
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine use among treatment-seeking adolescents in Southern California: participant characteristics and treatment response.
Rawson RA; Gonzales R; Obert JL; McCann MJ; Brethen P
J Subst Abuse Treat; 2005 Sep; 29(2):67-74. PubMed ID: 16135335
[TBL] [Abstract][Full Text] [Related]
15. A case-matched comparison of readmission patterns between primary methamphetamine-using and primary cocaine-using adolescents engaged in inpatient substance-abuse treatment.
Callaghan R; Taylor L; Victor JC; Lentz T
Addict Behav; 2007 Dec; 32(12):3101-6. PubMed ID: 17618062
[TBL] [Abstract][Full Text] [Related]
16. Impaired physical health among methamphetamine users in comparison with the general population: the role of methamphetamine dependence and opioid use.
McKetin R; Kelly E; McLaren J; Proudfoot H
Drug Alcohol Rev; 2008 Sep; 27(5):482-9. PubMed ID: 18608459
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine abuse: issues for special populations.
Freese TE; Obert J; Dickow A; Cohen J; Lord RH
J Psychoactive Drugs; 2000; 32(2):177-82. PubMed ID: 10908005
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal changes in methamphetamine and cocaine use in untreated rural stimulant users: racial differences and the impact of methamphetamine legislation.
Borders TF; Booth BM; Han X; Wright P; Leukefeld C; Falck RS; Carlson RG
Addiction; 2008 May; 103(5):800-8. PubMed ID: 18412758
[TBL] [Abstract][Full Text] [Related]
19. Is the self-report of recent cocaine or methamphetamine use reliable in illicit stimulant drug users who present to the Emergency Department with chest pain?
Lee MO; Vivier PM; Diercks DB
J Emerg Med; 2009 Aug; 37(2):237-41. PubMed ID: 19081702
[TBL] [Abstract][Full Text] [Related]
20. Young adult injection drug users in the United States continue to practice HIV risk behaviors.
Rondinelli AJ; Ouellet LJ; Strathdee SA; Latka MH; Hudson SM; Hagan H; Garfein RS
Drug Alcohol Depend; 2009 Sep; 104(1-2):167-74. PubMed ID: 19559543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
